CARD14-associated papulosquamous eruption flare-up after SARS-CoV-2 infection in a child: secukinumab a safe and effective treatment

Int J Dermatol. 2023 Oct;62(10):1304-1306. doi: 10.1111/ijd.16790. Epub 2023 Jul 8.

Authors

Marco A Chessa^{1

2}, Alice N Rossi², Maria F Baracca², Bianca M Piraccini^{1

2}, Iria Neri²

Affiliations

¹ Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
² Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum University of Bologna, Bologna, Italy.

PMID: 37421198
DOI: 10.1111/ijd.16790

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
CARD Signaling Adaptor Proteins
COVID-19* / complications
Child
Exanthema*
Guanylate Cyclase
Humans
Membrane Proteins
SARS-CoV-2

Substances

Antibodies, Monoclonal, Humanized
CARD Signaling Adaptor Proteins
CARD14 protein, human
Guanylate Cyclase
Membrane Proteins
secukinumab